Kenneth J Moise Jr., MD
Professor of Women’s Health
Dell Medical School – UT Austin
Director, Comprehensive Fetal Care Center Dell Children’s Medical Center
Austin, TX, USA
Kenneth J. Moise Jr, M.D. is a professor in the Division of Maternal-Fetal Medicine in the Department of Obstetrics and Gynecology, and Reproductive Sciences and in the Department of Pediatric Surgery at The John P. and Kathrine G. McGovern Medical School at The University of Texas Health Science Center at Houston (McGovern Medical School at UTHealth). He currently sees patients in The Fetal Center at Children’s Memorial Hermann Hospital in Houston.
Dr. Moise completed his residency in Obstetrics and Gynecology at Vanderbilt University followed by a fellowship in Maternal-Fetal Medicine at Baylor College of Medicine. Dr. Moise is the former Director of Maternal-Fetal Medicine at Baylor College of Medicine and at the University of North Carolina School of Medicine. He is the former President of the International Fetal Medicine and Surgery Society and served for many years as the Treasurer/Secretary of that organization. He is a founding member of the North American Fetal Treatment Network (NAFTNet) having served on its executive board and its steering committee. He is board certified in general Obstetrics and Gynecology as well as Maternal-Fetal Medicine.
Dr. Moise’s interest in fetal therapy spans a 30 year period. He is recognized world-wide for his contributions in the fetal treatment of Rh disease including the development of middle cerebral artery Doppler for the non-invasive detection of fetal anemia and the use of free fetal DNA to determine the fetal RND status in the U.S.. He was instrumental in the formation of the three fetal centers – the Center for Maternal and Infant Health at the University of North Carolina, the Texas Children’s Fetal Center in Houston and The Fetal Center at Children’s Memorial Hermann Hospital in Houston. In 2019, he was awarded the Lifetime Achievement Award by the Society for Maternal-Fetal Medicine for his work in Hemolytic Disease of the Fetus and Newborn.